Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tefferi

Showing results (11-20 of 346) with videos related to

Pageof 35
Sort By:
Mayo Clinic Proceedings|December 30, 1998
The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overviewA Tefferi
Bone Marrow Transplantation|March 11, 2010
Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing actA Tefferi
Seminars in Hematology|March 10, 2001
Chronic myeloid disorders: Classification and treatment overviewA Tefferi
American Journal of Hematology|February 14, 1998
Pregnancy and thrombocythemiaA Tefferi
The New England Journal of Medicine|April 27, 2000
Myelofibrosis with myeloid metaplasiaA Tefferi
International Journal of Oncology|May 11, 2011
Changing trends in the management of chronic granulocytic-leukemiaA Tefferi
Leukemia|July 14, 2011
Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up?A Tefferi
Seminars in Hematology|February 4, 1999
Introduction: overview of chronic myeloproliferative disordersA Tefferi
Blood Reviews|July 12, 2011
JAK inhibitors in myeloproliferative neoplasms: rationale, current data and perspectiveA Tefferi, A Pardanani
British Journal of Haematology|December 12, 2001
Pruritus in polycythaemia vera: prevalence, laboratory correlates and managementF Diehn, A Tefferi
Pageof 35

Showing results (11-20 of 346) with videos related to

Sort By:
Pageof 35
Mayo Clinic Proceedings|December 30, 1998
The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overviewA Tefferi
Bone Marrow Transplantation|March 11, 2010
Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing actA Tefferi
Seminars in Hematology|March 10, 2001
Chronic myeloid disorders: Classification and treatment overviewA Tefferi
American Journal of Hematology|February 14, 1998
Pregnancy and thrombocythemiaA Tefferi
The New England Journal of Medicine|April 27, 2000
Myelofibrosis with myeloid metaplasiaA Tefferi
International Journal of Oncology|May 11, 2011
Changing trends in the management of chronic granulocytic-leukemiaA Tefferi
Leukemia|July 14, 2011
Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up?A Tefferi
Seminars in Hematology|February 4, 1999
Introduction: overview of chronic myeloproliferative disordersA Tefferi
Blood Reviews|July 12, 2011
JAK inhibitors in myeloproliferative neoplasms: rationale, current data and perspectiveA Tefferi, A Pardanani
British Journal of Haematology|December 12, 2001
Pruritus in polycythaemia vera: prevalence, laboratory correlates and managementF Diehn, A Tefferi
Pageof 35